SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-124681
Filing Date
2023-12-08
Accepted
2023-12-08 16:05:29
Documents
12
Period of Report
2023-12-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2332442d1_8k.htm   iXBRL 8-K 25984
  Complete submission text file 0001104659-23-124681.txt   199535

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sls-20231206.xsd EX-101.SCH 3042
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sls-20231206_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sls-20231206_pre.xml EX-101.PRE 22378
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2332442d1_8k_htm.xml XML 3320
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 231475394
SIC: 2834 Pharmaceutical Preparations